McKesson Corporation (MCK)

Cost of Revenue

$101.70B

Quarterly · Period ending: · USD

MCK logo

MCK Cost of Revenue

Latest reported$101.70B
MCK Quarterly Cost of Revenue ($0.00 → $101.70B)
High-resolution chart · PNG

MCK cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

McKesson Corporation Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
101,695,000,000
92,251,000,000
102,473,000,000
99,608,000,000
94,548,000,000
87,903,000,000
92,074,000,000
90,505,000,000
76,327,000,000
72,892,000,000
77,866,000,000
74,317,000,000
71,674,000,000
65,942,000,000
67,532,000,000
67,150,000,000
64,218,000,000
62,882,000,000
65,304,000,000
63,351,000,000
59,780,000,000
55,982,000,000
59,592,000,000
57,951,000,000
53,121,000,000
55,430,000,000
56,252,000,000
54,867,000,000
53,053,000,000
49,526,000,000
53,464,000,000
50,392,000,000
49,985,000,000
48,761,000,000
51,095,000,000
49,353,000,000
48,612,000,000
46,024,000,000
47,420,000,000
47,316,000,000
46,826,000,000
43,826,000,000
45,027,000,000
45,917,000,000
44,698,000,000
42,008,000,000
44,063,000,000
41,835,000,000
41,261,000,000
35,601,000,000
32,466,000,000
30,945,000,000
30,288,000,000
28,624,000,000
29,519,000,000
28,130,000,000
29,198,000,000
29,854,000,000
29,273,000,000
28,569,000,000
28,471,000,000
27,102,000,000
26,786,000,000
26,168,000,000
26,058,000,000
25,060,000,000
26,817,000,000
25,795,000,000
25,354,000,000
24,759,000,000
25,787,000,000
25,272,000,000
25,436,000,000
24,784,000,000
25,290,000,000
23,269,000,000
23,351,000,000
22,914,000,000
22,050,000,000
21,362,000,000
22,593,000,000
21,725,000,000
21,619,000,000
20,711,000,000
20,133,000,000
19,574,700,000
19,941,300,000
19,199,300,000
18,334,600,000
17,023,700,000
17,498,100,000
15,998,400,000
15,737,700,000
14,001,500,000
14,193,400,000
12,951,000,000
12,875,500,000
12,212,100,000
12,511,300,000
11,491,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.